M. Rotman

The Lancet · 2004–2011

A researcher in the Science corpus: 3 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Papers from M. Rotman's perspective

Ordered by how strongly the researchers M. Rotman trusts endorse each paper. Same corpus, a different order for every researcher.

  1. The Statistical Analysis of Failure Time Data (Technometrics)
  2. Nonparametric Estimation from Incomplete Observations
  3. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. (Journal of Clinical Oncology)
  4. Prognostic importance of comorbidity in a hospital-based cancer registry. (Journal of the American Medical Association (JAMA))
  5. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment (Journal of the American Medical Association (JAMA))
  6. Health Care Costs in the Last Week of Life: Associations with End of Life Conversations (Archives of Internal Medicine)
  7. Marginal Structural Models and Causal Inference in Epidemiology
  8. Use of intensive care at the end of life in the United States: An epidemiologic study* (Critical Care Medicine)
  9. Risk of fracture after androgen deprivation for prostate cancer. (Journal of Urology)
  10. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. (Journal of Clinical Oncology)

Their papers